The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages

被引:123
|
作者
Martin, Darren P. [1 ]
Weaver, Steven [2 ]
Tegally, Houriiyah [3 ]
San, James Emmanuel [3 ]
Shank, Stephen D. [2 ]
Wilkinson, Eduan [3 ]
Lucaci, Alexander G. [2 ]
Giandhari, Jennifer [3 ]
Naidoo, Sureshnee [3 ]
Pillay, Yeshnee [3 ]
Singh, Lavanya [3 ]
Lessells, Richard J. [3 ]
Gupta, Ravindra K. [4 ,5 ]
Wertheim, Joel O. [6 ]
Nekturenko, Anton [7 ]
Murrell, Ben [8 ]
Harkins, Gordon W. [9 ]
Lemey, Philippe [10 ]
MacLean, Oscar A. [11 ]
Robertson, David L. [11 ]
de Oliveira, Tulio [3 ,12 ]
Pond, Sergei L. Kosakovsky [2 ]
机构
[1] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Integrat Biomed Sci, Div Computat Biol, ZA-7701 Cape Town, South Africa
[2] Temple Univ, Dept Biol, Inst Genom & Evolutionary Med, Philadelphia, PA 19122 USA
[3] Univ KwaZulu Natal, Sch Lab Med & Med Sci, KwaZulu Natal Res Innovat & Sequencing Platform, ZA-4001 Durban, South Africa
[4] Univ Cambridge, Clin Microbiol, Cambridge CB2 1TN, England
[5] Africa Hlth Res Inst, ZA-4013 Kwa Zulu, South Africa
[6] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[7] Penn State Univ, Dept Biochem & Mol Biol, State Coll, PA 16802 USA
[8] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-14183 Stockholm, Sweden
[9] Univ Western Cape, South African Natl Bioinformat Inst, South African Med Res Council, Capac Dev Unit, ZA-7635 Bellville, South Africa
[10] Katholieke Univ Leuven, Rega Inst, Dept Microbiol Immunol & Transplantat, B-3000 Leuven, Belgium
[11] Univ Glasgow, Ctr Virus Res, MRC, Glasgow 12 8QQ, Lanark, Scotland
[12] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA
基金
英国惠康基金; 美国国家卫生研究院; 英国医学研究理事会; 欧洲研究理事会; 美国国家科学基金会;
关键词
RECEPTOR-BINDING DOMAIN; MUTATIONS;
D O I
10.1016/j.cell.2021.09.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The independent emergence date in 2020 of the B.1.1.7, B.1.351, and P.1 lineages of SARS-CoV-2 prompted renewed concerns about the evolutionary capacity of this virus to overcome public health interventions and rising population immunity. Here, by examining patterns of synonymous and non-synonymous mutations that have accumulated in SARS-CoV-2 genomes since the pandemic began, we find that the emergence of these three "501Y lineages" coincided with a major global shift in the selective forces acting on various SARS-CoV-2 genes. Following their emergence, the adaptive evolution of 501Y lineage viruses has involved repeated selectively favored convergent mutations at 35 genome sites, mutations we refer to as the 501Y meta-signature. The ongoing convergence of viruses in many other lineages on this meta-signature suggests that it includes multiple mutation combinations capable of promoting the persistence of diverse SARS-CoV-2 lineages in the face of mounting host immune recognition.
引用
收藏
页码:5189 / +
页数:19
相关论文
共 50 条
  • [1] SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse
    Hongyan Huang
    Yichao Zhu
    Zubiao Niu
    Lulin Zhou
    Qiang Sun
    Cell Death & Differentiation, 2021, 28 : 2840 - 2842
  • [2] The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
    Liu, Yang
    Liu, Jianying
    Plante, Kenneth S.
    Plante, Jessica A.
    Xie, Xuping
    Zhang, Xianwen
    Ku, Zhiqiang
    An, Zhiqiang
    Scharton, Dionna
    Schindewolf, Craig
    Widen, Steven G.
    Menachery, Vineet D.
    Shi, Pei-Yong
    Weaver, Scott C.
    NATURE, 2022, 602 (7896) : 294 - +
  • [3] SARS-CoV-2 N501Y variants of concern and their potential transmission by mouse
    Huang, Hongyan
    Zhu, Yichao
    Niu, Zubiao
    Zhou, Lulin
    Sun, Qiang
    CELL DEATH AND DIFFERENTIATION, 2021, 28 (10): : 2840 - 2842
  • [4] The N501Y spike substitution enhances SARS-CoV-2 infection and transmission
    Yang Liu
    Jianying Liu
    Kenneth S. Plante
    Jessica A. Plante
    Xuping Xie
    Xianwen Zhang
    Zhiqiang Ku
    Zhiqiang An
    Dionna Scharton
    Craig Schindewolf
    Steven G. Widen
    Vineet D. Menachery
    Pei-Yong Shi
    Scott C. Weaver
    Nature, 2022, 602 : 294 - 299
  • [5] Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein
    Henrietta Onyinye Uzoeto
    Judith Nnedimkpa Ajima
    Amarachukwu Vivian Arazu
    Glory Omini Ibiang
    Samuel Cosmas
    Olanrewaju Ayodeji Durojaye
    Journal of Genetic Engineering and Biotechnology, 20
  • [6] Detection of SARS-CoV-2 N501Y mutation among SARS-CoV-2 variants of concern circulating in Northern Cyprus
    Tuncel, Gulten
    Ergoren, Mahmut Cerkez
    Baddal, Buket
    Tulay, Pinar
    Ozverel, Cenk Serhan
    Guler, Emrah
    Suer, Huseyin Kaya
    Sayan, Murat
    Sanlidag, Tamer
    FUTURE VIROLOGY, 2022, 17 (08) : 523 - 528
  • [7] Spreading of a new SARS-CoV-2 N501Y spike variant in a new lineage
    Colson, Philippe
    Levasseur, Anthony
    Delerce, Jeremy
    Pinault, Lucile
    Dudouet, Pierre
    Devaux, Christian
    Fournier, Pierre-Edouard
    La Scola, Bernard
    Lagier, Jean-Christophe
    Raoult, Didier
    CLINICAL MICROBIOLOGY AND INFECTION, 2021, 27 (09) : 1352.e1 - 1352.e5
  • [8] Immunity evasion: consequence of the N501Y mutation of the SARS-CoV-2 spike glycoprotein
    Uzoeto, Henrietta Onyinye
    Ajima, Judith Nnedimkpa
    Arazu, Amarachukwu Vivian
    Ibiang, Glory Omini
    Cosmas, Samuel
    Durojaye, Olanrewaju Ayodeji
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2022, 20 (01)
  • [9] The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence
    Salimovic-Besic, Irma
    Dedeic-Ljubovic, Amela
    Zahirovic, Edina
    Hasanovic, Medina
    Sehic, Merima
    Vukovikj, Maja
    Boshevska, Golubinka
    Vegar-Zubovic, Sandra
    Mehmedika-Suljic, Enra
    Izetbegovic, Sebija
    HELIYON, 2022, 8 (12)
  • [10] Efficacy of Serotherapy on an N501Y Variant of SARS-CoV-2 in a Patient With Chronic Lymphocytic Leukemia
    Vercueil, Colin
    Eberst, Lauriane
    Humbrecht, Catherine
    Fornecker, Luc-Matthieu
    HEMASPHERE, 2021, 5 (12): : E655